JP2005528374A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005528374A5 JP2005528374A5 JP2003581743A JP2003581743A JP2005528374A5 JP 2005528374 A5 JP2005528374 A5 JP 2005528374A5 JP 2003581743 A JP2003581743 A JP 2003581743A JP 2003581743 A JP2003581743 A JP 2003581743A JP 2005528374 A5 JP2005528374 A5 JP 2005528374A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- carbon atoms
- group
- amino
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CN1C(*)=C(*)N(*)C1 Chemical compound CN1C(*)=C(*)N(*)C1 0.000 description 17
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02007699 | 2002-04-05 | ||
| PCT/EP2003/003434 WO2003084503A2 (en) | 2002-04-05 | 2003-04-02 | P38 kinase inhibitors for treating mucus hypersecretion_ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005528374A JP2005528374A (ja) | 2005-09-22 |
| JP2005528374A5 true JP2005528374A5 (enExample) | 2006-06-01 |
Family
ID=28685842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003581743A Pending JP2005528374A (ja) | 2002-04-05 | 2003-04-02 | 粘液分泌過多の治療方法 |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1494645A2 (enExample) |
| JP (1) | JP2005528374A (enExample) |
| KR (1) | KR20040101398A (enExample) |
| CN (1) | CN1658834A (enExample) |
| AU (1) | AU2003224025A1 (enExample) |
| BR (1) | BR0309009A (enExample) |
| CA (1) | CA2479520A1 (enExample) |
| IL (1) | IL163737A0 (enExample) |
| MX (1) | MXPA04009605A (enExample) |
| NZ (1) | NZ536278A (enExample) |
| PL (1) | PL372963A1 (enExample) |
| RU (1) | RU2004132847A (enExample) |
| WO (1) | WO2003084503A2 (enExample) |
| ZA (1) | ZA200406910B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070010529A1 (en) * | 2003-05-19 | 2007-01-11 | Kanji Takahashi | Nitrogenous heterocyclic compounds and medical use thereof |
| US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
| US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
| WO2006137421A1 (ja) * | 2005-06-21 | 2006-12-28 | Kyowa Hakko Kogyo Co., Ltd. | 局所投与剤 |
| FR2903774B1 (fr) * | 2006-07-17 | 2008-09-05 | Renault Sas | Procede de validation d'un diagnostic de fontionnement d'un dispositif. |
| BRPI0920707A2 (pt) | 2008-10-02 | 2015-12-29 | Respivert Ltd | compostos |
| GB0818033D0 (en) | 2008-10-02 | 2008-11-05 | Respivert Ltd | Novel compound |
| MX2011006219A (es) | 2008-12-11 | 2011-06-28 | Respivert Ltd | Inhibidores de la proteina cinasa activada por el mitogeno p38. |
| GB0905955D0 (en) | 2009-04-06 | 2009-05-20 | Respivert Ltd | Novel compounds |
| ES2927715T3 (es) | 2017-10-05 | 2022-11-10 | Fulcrum Therapeutics Inc | Inhibidores de la quinasa p38 reducen la expresión de dux4 y de los genes que le siguen para el tratamiento de la FSHD |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6184226B1 (en) * | 1998-08-28 | 2001-02-06 | Scios Inc. | Quinazoline derivatives as inhibitors of P-38 α |
| TR200102817T2 (tr) * | 1999-03-12 | 2002-05-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | Antiinflamatuar ajanlar olarak faydalı bileşikler |
| HUP0201261A3 (en) * | 1999-05-21 | 2003-12-29 | Scios Inc Sunnyvale | Indole-type derivatives as inhibitors of p38 kinase and pharmaceutical compositions containing them |
| KR20080028516A (ko) * | 1999-08-19 | 2008-03-31 | 시그널 파머슈티컬스 인크 | Ｊｎｋ억제제로서의 피라졸로안트론과 그 유도체 및 이를함유하는 조성물 |
| KR20020032591A (ko) * | 1999-09-17 | 2002-05-03 | 스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 | 라이노바이러스 감염에서의 ｃｓａｉｄ의 용도 |
| AU2001290912A1 (en) * | 2000-09-15 | 2002-03-26 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| EP1337250A2 (en) * | 2000-10-19 | 2003-08-27 | SmithKline Beecham Corporation | Use of p38 inhibitors for the treatment of smoke inhalation |
| JP2005504727A (ja) * | 2001-04-13 | 2005-02-17 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 抗炎症薬として有用なウレア化合物 |
| IL161667A0 (en) * | 2001-11-09 | 2004-09-27 | Scios Inc | Method and composition to treat cystic fibrosis |
-
2003
- 2003-04-02 KR KR10-2004-7015891A patent/KR20040101398A/ko not_active Withdrawn
- 2003-04-02 CN CN038129884A patent/CN1658834A/zh active Pending
- 2003-04-02 NZ NZ536278A patent/NZ536278A/en unknown
- 2003-04-02 MX MXPA04009605A patent/MXPA04009605A/es unknown
- 2003-04-02 CA CA002479520A patent/CA2479520A1/en not_active Abandoned
- 2003-04-02 JP JP2003581743A patent/JP2005528374A/ja active Pending
- 2003-04-02 IL IL16373703A patent/IL163737A0/xx unknown
- 2003-04-02 PL PL03372963A patent/PL372963A1/xx not_active Application Discontinuation
- 2003-04-02 RU RU2004132847/15A patent/RU2004132847A/ru not_active Application Discontinuation
- 2003-04-02 WO PCT/EP2003/003434 patent/WO2003084503A2/en not_active Ceased
- 2003-04-02 AU AU2003224025A patent/AU2003224025A1/en not_active Abandoned
- 2003-04-02 EP EP03720407A patent/EP1494645A2/en not_active Ceased
- 2003-04-02 BR BR0309009-4A patent/BR0309009A/pt not_active IP Right Cessation
-
2004
- 2004-08-31 ZA ZA200406910A patent/ZA200406910B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2004133034A (ru) | Новые фармацевтические композиции на основе антихолинергических средств и ингибиторов киназы р38 | |
| JP2005529098A5 (enExample) | ||
| JP2002539198A5 (enExample) | ||
| JP2004536845A5 (enExample) | ||
| JP2003514808A5 (enExample) | ||
| CA2352524A1 (en) | Aromatic heterocyclic compounds as antiinflammatory agents | |
| JP2005518447A5 (enExample) | ||
| CA2511970A1 (en) | Urea derivatives useful in the treatment of heart failure | |
| JP2002539206A5 (enExample) | ||
| JP2008525502A5 (enExample) | ||
| JP2005503400A5 (enExample) | ||
| US20040110755A1 (en) | Combination therapy with p38 MAP kinase inhibitors and their pharmaceutical compositions | |
| JPWO2011162343A1 (ja) | キナーゼ阻害作用を有する化合物の併用による抗腫瘍剤 | |
| WO2023001028A1 (zh) | 杂芳-3-哌啶二酮类化合物及其应用 | |
| JP2020527575A5 (enExample) | ||
| RU2004132847A (ru) | Способ лечения гиперсекреции слизи | |
| JP2005538066A5 (enExample) | ||
| US7276491B2 (en) | Anticoagulant and fibrinolytic therapy using p38 MAP kinase inhibitors | |
| US20030220336A1 (en) | Method of treating mucus hypersecretion | |
| TWI769395B (zh) | 以吡唑并[3,4-d]嘧啶化合物為有效成分之治療劑 | |
| DE60310730T2 (de) | Pharmazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege | |
| RU2021102256A (ru) | Производные хиназолина биарилэфирного типа | |
| JPWO2014007065A1 (ja) | 固形医薬錠剤およびその製造方法 | |
| DE12621T1 (de) | Schmerzlinderndes Arzneimittel |